Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Anti-angiogenic trials; key highlights of the 14th WCGC

Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium
Anti-angiogenic trials; key highlights of the 14th WCGC ( Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium )
17 Jul 2012

The immuno side of melanoma

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
The immuno side of melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
16 Jul 2012

Constructing successful biomarker clinical trials

Dr Lisa McShane – National Cancer Institute, Bethesda, USA
Constructing successful biomarker clinical trials ( Dr Lisa McShane – National Cancer Institute, Bethesda, USA )
16 Jul 2012

Highlights of the 22nd EACR meeting and tackling glioblastoma

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012

The changing field of drug development

Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly
The changing field of drug development ( Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly )
16 Jul 2012

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain )
16 Jul 2012

Perifosine disappoints in refractory mCRC

Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
Perifosine disappoints in refractory mCRC ( Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA )
16 Jul 2012

Screening and specialist nurses central to patient care

Jola Gore-Booth – EuropaColon, France / UK
Screening and specialist nurses central to patient care ( Jola Gore-Booth – EuropaColon, France / UK )
16 Jul 2012

Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment

Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy
Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment ( Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy )
16 Jul 2012

Adjuvant cetuximab disappoints again in mCRC

Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC ( Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France )
16 Jul 2012

Young Voices United against CRC

Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia
Young Voices United against CRC ( Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia )
16 Jul 2012

Advances in radiotherapy for rectal cancer

Dr Karin Haustermans – University Hospital Leuven, Belgium
Advances in radiotherapy for rectal cancer ( Dr Karin Haustermans – University Hospital Leuven, Belgium )
16 Jul 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation